Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.

Kazutoshi Aoyama, Asim Saha, Jakub Tolar, Megan J. Riddle, Rachelle G. Veenstra, Patricia A. Taylor, Rune Blomhoff, Angela Panoskaltsis-Mortari, Christopher A. Klebanoff, Gérard Socié, David H. Munn, William J Murphy, Jonathan S. Serody, Leshara M. Fulton, Takanori Teshima, Roshantha A. Chandraratna, Ethan Dmitrovsky, Yanxia Guo, Randolph J. Noelle, Bruce R. Blazar

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Graft-versus-host disease (GVHD) is a critical complication after allogeneic bone marrow transplantation. During GVHD, donor T cells are activated by host antigen-presenting cells and differentiate into T-effector cells (Teffs) that migrate to GVHD target organs. However, local environmental factors influencing Teff differentiation and migration are largely unknown. Vitamin A metabolism within the intestine produces retinoic acid, which contributes to intestinal homeostasis and tolerance induction. Here, we show that the expression and function of vitamin A-metabolizing enzymes were increased in the intestine and mesenteric lymph nodes in mice with active GVHD. Moreover, transgenic donor T cells expressing a retinoic acid receptor (RAR) response element luciferase reporter responded to increased vitamin A metabolites in GVHD-affected organs. Increasing RAR signaling accelerated GVHD lethality, whereas donor T cells expressing a dominant-negative RARα (dnRARα) showed markedly diminished lethality. The dnRARα transgenic T cells showed reduced Th1 differentiation and α4β7 and CCR9 expression associated with poor intestinal migration, low GVHD pathology, and reduced intestinal permeability, primarily via CD4(+) T cells. The inhibition of RAR signaling augmented donor-induced Treg generation and expansion in vivo, while preserving graft-versus-leukemia effects. Together, these results suggested that reagents blunting donor T-cell RAR signaling may possess therapeutic anti-GVHD properties.

Original languageEnglish (US)
Pages (from-to)2125-2134
Number of pages10
JournalBlood
Volume122
Issue number12
DOIs
StatePublished - Sep 19 2013

Fingerprint

T-cells
Graft vs Host Disease
Tretinoin
Grafts
Cell Differentiation
Retinoic Acid Receptors
T-Lymphocytes
Vitamin A
Intestines
Eragrostis
Transplantation (surgical)
Homologous Transplantation
Response Elements
Antigen-Presenting Cells
Luciferases
Bone Marrow Transplantation
Pathology
Metabolites
Metabolism
Permeability

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Aoyama, K., Saha, A., Tolar, J., Riddle, M. J., Veenstra, R. G., Taylor, P. A., ... Blazar, B. R. (2013). Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration. Blood, 122(12), 2125-2134. https://doi.org/10.1182/blood-2012-11-470252

Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration. / Aoyama, Kazutoshi; Saha, Asim; Tolar, Jakub; Riddle, Megan J.; Veenstra, Rachelle G.; Taylor, Patricia A.; Blomhoff, Rune; Panoskaltsis-Mortari, Angela; Klebanoff, Christopher A.; Socié, Gérard; Munn, David H.; Murphy, William J; Serody, Jonathan S.; Fulton, Leshara M.; Teshima, Takanori; Chandraratna, Roshantha A.; Dmitrovsky, Ethan; Guo, Yanxia; Noelle, Randolph J.; Blazar, Bruce R.

In: Blood, Vol. 122, No. 12, 19.09.2013, p. 2125-2134.

Research output: Contribution to journalArticle

Aoyama, K, Saha, A, Tolar, J, Riddle, MJ, Veenstra, RG, Taylor, PA, Blomhoff, R, Panoskaltsis-Mortari, A, Klebanoff, CA, Socié, G, Munn, DH, Murphy, WJ, Serody, JS, Fulton, LM, Teshima, T, Chandraratna, RA, Dmitrovsky, E, Guo, Y, Noelle, RJ & Blazar, BR 2013, 'Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.', Blood, vol. 122, no. 12, pp. 2125-2134. https://doi.org/10.1182/blood-2012-11-470252
Aoyama, Kazutoshi ; Saha, Asim ; Tolar, Jakub ; Riddle, Megan J. ; Veenstra, Rachelle G. ; Taylor, Patricia A. ; Blomhoff, Rune ; Panoskaltsis-Mortari, Angela ; Klebanoff, Christopher A. ; Socié, Gérard ; Munn, David H. ; Murphy, William J ; Serody, Jonathan S. ; Fulton, Leshara M. ; Teshima, Takanori ; Chandraratna, Roshantha A. ; Dmitrovsky, Ethan ; Guo, Yanxia ; Noelle, Randolph J. ; Blazar, Bruce R. / Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration. In: Blood. 2013 ; Vol. 122, No. 12. pp. 2125-2134.
@article{ed425684b7db4c6dbfd8ca75455afa97,
title = "Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.",
abstract = "Graft-versus-host disease (GVHD) is a critical complication after allogeneic bone marrow transplantation. During GVHD, donor T cells are activated by host antigen-presenting cells and differentiate into T-effector cells (Teffs) that migrate to GVHD target organs. However, local environmental factors influencing Teff differentiation and migration are largely unknown. Vitamin A metabolism within the intestine produces retinoic acid, which contributes to intestinal homeostasis and tolerance induction. Here, we show that the expression and function of vitamin A-metabolizing enzymes were increased in the intestine and mesenteric lymph nodes in mice with active GVHD. Moreover, transgenic donor T cells expressing a retinoic acid receptor (RAR) response element luciferase reporter responded to increased vitamin A metabolites in GVHD-affected organs. Increasing RAR signaling accelerated GVHD lethality, whereas donor T cells expressing a dominant-negative RARα (dnRARα) showed markedly diminished lethality. The dnRARα transgenic T cells showed reduced Th1 differentiation and α4β7 and CCR9 expression associated with poor intestinal migration, low GVHD pathology, and reduced intestinal permeability, primarily via CD4(+) T cells. The inhibition of RAR signaling augmented donor-induced Treg generation and expansion in vivo, while preserving graft-versus-leukemia effects. Together, these results suggested that reagents blunting donor T-cell RAR signaling may possess therapeutic anti-GVHD properties.",
author = "Kazutoshi Aoyama and Asim Saha and Jakub Tolar and Riddle, {Megan J.} and Veenstra, {Rachelle G.} and Taylor, {Patricia A.} and Rune Blomhoff and Angela Panoskaltsis-Mortari and Klebanoff, {Christopher A.} and G{\'e}rard Soci{\'e} and Munn, {David H.} and Murphy, {William J} and Serody, {Jonathan S.} and Fulton, {Leshara M.} and Takanori Teshima and Chandraratna, {Roshantha A.} and Ethan Dmitrovsky and Yanxia Guo and Noelle, {Randolph J.} and Blazar, {Bruce R.}",
year = "2013",
month = "9",
day = "19",
doi = "10.1182/blood-2012-11-470252",
language = "English (US)",
volume = "122",
pages = "2125--2134",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.

AU - Aoyama, Kazutoshi

AU - Saha, Asim

AU - Tolar, Jakub

AU - Riddle, Megan J.

AU - Veenstra, Rachelle G.

AU - Taylor, Patricia A.

AU - Blomhoff, Rune

AU - Panoskaltsis-Mortari, Angela

AU - Klebanoff, Christopher A.

AU - Socié, Gérard

AU - Munn, David H.

AU - Murphy, William J

AU - Serody, Jonathan S.

AU - Fulton, Leshara M.

AU - Teshima, Takanori

AU - Chandraratna, Roshantha A.

AU - Dmitrovsky, Ethan

AU - Guo, Yanxia

AU - Noelle, Randolph J.

AU - Blazar, Bruce R.

PY - 2013/9/19

Y1 - 2013/9/19

N2 - Graft-versus-host disease (GVHD) is a critical complication after allogeneic bone marrow transplantation. During GVHD, donor T cells are activated by host antigen-presenting cells and differentiate into T-effector cells (Teffs) that migrate to GVHD target organs. However, local environmental factors influencing Teff differentiation and migration are largely unknown. Vitamin A metabolism within the intestine produces retinoic acid, which contributes to intestinal homeostasis and tolerance induction. Here, we show that the expression and function of vitamin A-metabolizing enzymes were increased in the intestine and mesenteric lymph nodes in mice with active GVHD. Moreover, transgenic donor T cells expressing a retinoic acid receptor (RAR) response element luciferase reporter responded to increased vitamin A metabolites in GVHD-affected organs. Increasing RAR signaling accelerated GVHD lethality, whereas donor T cells expressing a dominant-negative RARα (dnRARα) showed markedly diminished lethality. The dnRARα transgenic T cells showed reduced Th1 differentiation and α4β7 and CCR9 expression associated with poor intestinal migration, low GVHD pathology, and reduced intestinal permeability, primarily via CD4(+) T cells. The inhibition of RAR signaling augmented donor-induced Treg generation and expansion in vivo, while preserving graft-versus-leukemia effects. Together, these results suggested that reagents blunting donor T-cell RAR signaling may possess therapeutic anti-GVHD properties.

AB - Graft-versus-host disease (GVHD) is a critical complication after allogeneic bone marrow transplantation. During GVHD, donor T cells are activated by host antigen-presenting cells and differentiate into T-effector cells (Teffs) that migrate to GVHD target organs. However, local environmental factors influencing Teff differentiation and migration are largely unknown. Vitamin A metabolism within the intestine produces retinoic acid, which contributes to intestinal homeostasis and tolerance induction. Here, we show that the expression and function of vitamin A-metabolizing enzymes were increased in the intestine and mesenteric lymph nodes in mice with active GVHD. Moreover, transgenic donor T cells expressing a retinoic acid receptor (RAR) response element luciferase reporter responded to increased vitamin A metabolites in GVHD-affected organs. Increasing RAR signaling accelerated GVHD lethality, whereas donor T cells expressing a dominant-negative RARα (dnRARα) showed markedly diminished lethality. The dnRARα transgenic T cells showed reduced Th1 differentiation and α4β7 and CCR9 expression associated with poor intestinal migration, low GVHD pathology, and reduced intestinal permeability, primarily via CD4(+) T cells. The inhibition of RAR signaling augmented donor-induced Treg generation and expansion in vivo, while preserving graft-versus-leukemia effects. Together, these results suggested that reagents blunting donor T-cell RAR signaling may possess therapeutic anti-GVHD properties.

UR - http://www.scopus.com/inward/record.url?scp=84885458195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885458195&partnerID=8YFLogxK

U2 - 10.1182/blood-2012-11-470252

DO - 10.1182/blood-2012-11-470252

M3 - Article

C2 - 23814022

AN - SCOPUS:84885458195

VL - 122

SP - 2125

EP - 2134

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -